These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28532352)

  • 1. Understanding Glaucomatous Optic Neuropathy: The Synergy Between Clinical Observation and Investigation.
    Quigley HA
    Annu Rev Vis Sci; 2016 Oct; 2():235-254. PubMed ID: 28532352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some current ideas on the pathogenesis and the role of neuroprotection in glaucomatous optic neuropathy.
    Osborne NN; Chidlow G; Wood J; Casson R
    Eur J Ophthalmol; 2003 Apr; 13 Suppl 3():S19-26. PubMed ID: 12749673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we treat the brain in glaucoma?
    Gupta N; Yücel YH
    Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy.
    Levin LA
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S98-101. PubMed ID: 10416753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of retinal ganglion cell damage in glaucomatous optic neuropathy: Axon transport, injury and soma loss.
    Nuschke AC; Farrell SR; Levesque JM; Chauhan BC
    Exp Eye Res; 2015 Dec; 141():111-24. PubMed ID: 26070986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of neuroprotection in glaucoma.
    Wein FB; Levin LA
    Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optic nerve and neuroprotection strategies.
    Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
    Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
    Hare WA; WoldeMussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2640-51. PubMed ID: 15277487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The connective tissue phenotype of glaucomatous cupping in the monkey eye - Clinical and research implications.
    Yang H; Reynaud J; Lockwood H; Williams G; Hardin C; Reyes L; Stowell C; Gardiner SK; Burgoyne CF
    Prog Retin Eye Res; 2017 Jul; 59():1-52. PubMed ID: 28300644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The morphological difference between glaucoma and other optic neuropathies.
    Burgoyne C
    J Neuroophthalmol; 2015 Sep; 35 Suppl 1(0 1):S8-S21. PubMed ID: 26274837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.
    Neufeld AH
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S129-35. PubMed ID: 10416755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
    Attarzadeh A; Hosseini H; Nowroozizadeh S
    Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage.
    Morgan JE
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():437-44. PubMed ID: 11026971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma.
    Quigley HA; Pitha IF; Welsbie DS; Nguyen C; Steinhart MR; Nguyen TD; Pease ME; Oglesby EN; Berlinicke CA; Mitchell KL; Kim J; Jefferys JJ; Kimball EC
    PLoS One; 2015; 10(10):e0141137. PubMed ID: 26505191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucoma as a neurodegenerative disease.
    Gupta N; Yücel YH
    Curr Opin Ophthalmol; 2007 Mar; 18(2):110-4. PubMed ID: 17301611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glaucoma--neurodegenerative disease].
    Tataru LC; Bogdănici CM
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1120-5. PubMed ID: 20191885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.